ID

22849

Description

Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00477269

Link

https://clinicaltrials.gov/show/NCT00477269

Keywords

Versions (1)
  1. 6/13/17 6/13/17 -
Uploaded on

June 13, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Pulmonary Arterial Hypertension NCT00477269

English

Eligibility Pulmonary Arterial Hypertension NCT00477269

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of pah of either primary (idiopathic), familial or secondary to systemic sclerosis (excluding those with marked pulmonary fibrosis) according to world conference on pulmonary hypertension classification (venice, 2003).
Description

Pulmonary arterial hypertension | Familial pulmonary arterial hypertension | Pulmonary arterial hypertension Secondary to Systemic Scleroderma | Pulmonary Fibrosis Marked

Data type

boolean

Alias
UMLS CUI [1]
C2973725
UMLS CUI [2]
C1701939
UMLS CUI [3,1]
C3665995
UMLS CUI [3,2]
C0175668
UMLS CUI [3,3]
C0036421
UMLS CUI [4,1]
C0034069
UMLS CUI [4,2]
C1706089
symptoms with a who class of ii-iv
Description

Symptoms WHO Pulmonary arterial hypertension Class Functional

Data type

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0043237
UMLS CUI [1,3]
C2973725
UMLS CUI [1,4]
C0456387
UMLS CUI [1,5]
C0205245
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of unspecific phosphodiesterase inhibitors (for example, pentoxyfillin, enoximon, milrinone or pimobendan) during the study
Description

Phosphodiesterase Inhibitors | Pentoxifylline | Enoximone | Milrinone | pimobendan

Data type

boolean

Alias
UMLS CUI [1]
C0031638
UMLS CUI [2]
C0030899
UMLS CUI [3]
C0116190
UMLS CUI [4]
C0128513
UMLS CUI [5]
C0071071
chronic inhaled nitric oxide therapy from start to study completion
Description

Nitric oxide therapy Inhaled chronic

Data type

boolean

Alias
UMLS CUI [1,1]
C1135474
UMLS CUI [1,2]
C0001559
UMLS CUI [1,3]
C0205191
treatment with catecholamines (for example, adrenalin, noradrenalin, dopamine),
Description

Catecholamines | Adrenalin | Norepinephrine | Dopamine

Data type

boolean

Alias
UMLS CUI [1]
C0007412
UMLS CUI [2]
C1963284
UMLS CUI [3]
C0028351
UMLS CUI [4]
C0013030
pre-existing lung diseases, including parasitic diseases affecting lungs, asthma, congenital abnormalities of the lungs, chest, and diaphragm.
Description

Lung diseases Pre-existing | Parasitic Diseases Affecting Lungs | Asthma | Congenital anomaly of lung | Abnormality of the thorax Congenital | Abnormality of the diaphragm Congenital

Data type

boolean

Alias
UMLS CUI [1,1]
C0024115
UMLS CUI [1,2]
C2347662
UMLS CUI [2,1]
C0030499
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0024109
UMLS CUI [3]
C0004096
UMLS CUI [4]
C0158644
UMLS CUI [5,1]
C4021797
UMLS CUI [5,2]
C1744681
UMLS CUI [6,1]
C1848873
UMLS CUI [6,2]
C1744681
pulmonary artery or valve stenosis; pulmonary venous hypertension; chronic thromboembolic pulmonary hypertension
Description

Pulmonary artery stenosis | Pulmonary Valve Stenosis | Venous hypertension pulmonary | Chronic thromboembolic pulmonary hypertension

Data type

boolean

Alias
UMLS CUI [1]
C0238397
UMLS CUI [2]
C0034089
UMLS CUI [3,1]
C0340766
UMLS CUI [3,2]
C0024109
UMLS CUI [4]
C2363973
acute heart failure or chronic left sided heart failure; congenital or acquired valvular or myocardial disease
Description

Heart failure | Chronic left-sided heart failure | Valvular disease Congenital | Valvular disease Acquired | Cardiomyopathy Congenital | Cardiomyopathy Acquired

Data type

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2]
C0264726
UMLS CUI [3,1]
C3258293
UMLS CUI [3,2]
C1744681
UMLS CUI [4,1]
C3258293
UMLS CUI [4,2]
C0439661
UMLS CUI [5,1]
C0878544
UMLS CUI [5,2]
C1744681
UMLS CUI [6,1]
C0878544
UMLS CUI [6,2]
C0439661
severe (systemic) arterial hypertension (> 200 mmhg (systolic) or > 120 mmhg (diastolic)) other protocol-defined inclusion/exclusion criteria may apply
Description

Hypertensive disease Severe | Systolic Pressure | Diastolic blood pressure | Clinical Trial Eligibility Criteria Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C0020538
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
UMLS CUI [4,1]
C1516637
UMLS CUI [4,2]
C2348563
Back to the top of the page

Similar models

Eligibility Pulmonary Arterial Hypertension NCT00477269

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Pulmonary arterial hypertension | Familial pulmonary arterial hypertension | Pulmonary arterial hypertension Secondary to Systemic Scleroderma | Pulmonary Fibrosis Marked
Item
diagnosis of pah of either primary (idiopathic), familial or secondary to systemic sclerosis (excluding those with marked pulmonary fibrosis) according to world conference on pulmonary hypertension classification (venice, 2003).
boolean
C2973725 (UMLS CUI [1])
C1701939 (UMLS CUI [2])
C3665995 (UMLS CUI [3,1])
C0175668 (UMLS CUI [3,2])
C0036421 (UMLS CUI [3,3])
C0034069 (UMLS CUI [4,1])
C1706089 (UMLS CUI [4,2])
Symptoms WHO Pulmonary arterial hypertension Class Functional
Item
symptoms with a who class of ii-iv
boolean
C1457887 (UMLS CUI [1,1])
C0043237 (UMLS CUI [1,2])
C2973725 (UMLS CUI [1,3])
C0456387 (UMLS CUI [1,4])
C0205245 (UMLS CUI [1,5])
Item Group
C0680251 (UMLS CUI)
Phosphodiesterase Inhibitors | Pentoxifylline | Enoximone | Milrinone | pimobendan
Item
use of unspecific phosphodiesterase inhibitors (for example, pentoxyfillin, enoximon, milrinone or pimobendan) during the study
boolean
C0031638 (UMLS CUI [1])
C0030899 (UMLS CUI [2])
C0116190 (UMLS CUI [3])
C0128513 (UMLS CUI [4])
C0071071 (UMLS CUI [5])
Nitric oxide therapy Inhaled chronic
Item
chronic inhaled nitric oxide therapy from start to study completion
boolean
C1135474 (UMLS CUI [1,1])
C0001559 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
Catecholamines | Adrenalin | Norepinephrine | Dopamine
Item
treatment with catecholamines (for example, adrenalin, noradrenalin, dopamine),
boolean
C0007412 (UMLS CUI [1])
C1963284 (UMLS CUI [2])
C0028351 (UMLS CUI [3])
C0013030 (UMLS CUI [4])
Lung diseases Pre-existing | Parasitic Diseases Affecting Lungs | Asthma | Congenital anomaly of lung | Abnormality of the thorax Congenital | Abnormality of the diaphragm Congenital
Item
pre-existing lung diseases, including parasitic diseases affecting lungs, asthma, congenital abnormalities of the lungs, chest, and diaphragm.
boolean
C0024115 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C0030499 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0024109 (UMLS CUI [2,3])
C0004096 (UMLS CUI [3])
C0158644 (UMLS CUI [4])
C4021797 (UMLS CUI [5,1])
C1744681 (UMLS CUI [5,2])
C1848873 (UMLS CUI [6,1])
C1744681 (UMLS CUI [6,2])
Pulmonary artery stenosis | Pulmonary Valve Stenosis | Venous hypertension pulmonary | Chronic thromboembolic pulmonary hypertension
Item
pulmonary artery or valve stenosis; pulmonary venous hypertension; chronic thromboembolic pulmonary hypertension
boolean
C0238397 (UMLS CUI [1])
C0034089 (UMLS CUI [2])
C0340766 (UMLS CUI [3,1])
C0024109 (UMLS CUI [3,2])
C2363973 (UMLS CUI [4])
Heart failure | Chronic left-sided heart failure | Valvular disease Congenital | Valvular disease Acquired | Cardiomyopathy Congenital | Cardiomyopathy Acquired
Item
acute heart failure or chronic left sided heart failure; congenital or acquired valvular or myocardial disease
boolean
C0018801 (UMLS CUI [1])
C0264726 (UMLS CUI [2])
C3258293 (UMLS CUI [3,1])
C1744681 (UMLS CUI [3,2])
C3258293 (UMLS CUI [4,1])
C0439661 (UMLS CUI [4,2])
C0878544 (UMLS CUI [5,1])
C1744681 (UMLS CUI [5,2])
C0878544 (UMLS CUI [6,1])
C0439661 (UMLS CUI [6,2])
Hypertensive disease Severe | Systolic Pressure | Diastolic blood pressure | Clinical Trial Eligibility Criteria Study Protocol
Item
severe (systemic) arterial hypertension (> 200 mmhg (systolic) or > 120 mmhg (diastolic)) other protocol-defined inclusion/exclusion criteria may apply
boolean
C0020538 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
C1516637 (UMLS CUI [4,1])
C2348563 (UMLS CUI [4,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial